论文部分内容阅读
目的:研究黄芪麦苓汤联合阿斯美治疗感冒后反复性咳嗽的临床效果。方法:将我院74例感冒后反复性咳嗽患儿抽签随机分为观察组与对照组,两组均37例,观察组采取黄芪麦苓汤联合阿斯美治疗,对照组单一阿斯美治疗,比较两组治疗1疗程后临床疗效、治疗前后咳嗽症状评分变化及咳嗽症状缓解时间,并对用药期间不良反应进行观察。结果:治疗后观察组咳嗽症状评分为(1.13±0.52)分与对照组(3.64±1.02)分比较显著较低(P<0.05),观察组咳嗽消失时间(4.11±1.25)天与对照组(5.97±1.58)天比较显著较低(P<0.05);观察组治疗总有效率为94.59%与对照组75.68%比较显著较高(P<0.05),差异有统计学意义(P<0.05);对照组1例食欲不振,1例恶心,观察组2例恶心,1例皮肤轻度发红,不良反应均轻微,无需处理或短暂停药均自行缓解,不良反应发生率比较(χ2=0.215,P<0.05)。结论:黄芪麦苓汤联合阿斯美治疗感冒后反复性咳嗽疗效确切,可缩短患儿咳嗽持续时间,且无明显不良反应,安全可靠。
Objective: To study the clinical effect of Astragalus Meiling Decoction combined with Asmes on recurrent cough after cold. Methods: 74 patients with recurrent cold cough in our hospital were randomized into observation group and control group. There were 37 patients in both groups. The observation group was treated with Astragalus Meiling Decoction combined with Asmeme and the control group with single Asmeme . The clinical curative effect, cough symptom scores and cough symptom relief time before and after treatment were compared between the two groups after one course of treatment. Adverse reactions were observed during the treatment. Results: After treatment, the score of cough in observation group was significantly lower (1.13 ± 0.52) than that of control group (3.64 ± 1.02) (P <0.05), and the disappearance time of cough in observation group was 4.11 ± 1.25 days compared with that of control group 5.97 ± 1.58). The total effective rate in the observation group was 94.59%, which was significantly higher than that in the control group (75.68%) (P <0.05). The difference was statistically significant (P <0.05). In the control group, 1 patient had loss of appetite and 1 patient with nausea. The nausea was observed in 2 patients in the observation group and mild skin redness in 1 patient. The side effects were mild and were relieved spontaneously without treatment or short-term withdrawal (χ2 = 0.215, P <0.05). Conclusion: Huangqi Mailing Decoction combined with Asmes treatment of recurrent cold cough curative effect is exact, can shorten the duration of cough in children with no obvious adverse reactions, safe and reliable.